nodes	percent_of_prediction	percent_of_DWPC	metapath
Tasosartan—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0599	0.0879	CbGbCtD
Tasosartan—CYP3A4—Trimethadione—epilepsy syndrome	0.0556	0.0817	CbGbCtD
Tasosartan—CYP3A4—Felbamate—epilepsy syndrome	0.0556	0.0817	CbGbCtD
Tasosartan—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0523	0.0768	CbGbCtD
Tasosartan—CYP3A4—Clonazepam—epilepsy syndrome	0.0473	0.0694	CbGbCtD
Tasosartan—CYP3A4—Clobazam—epilepsy syndrome	0.0454	0.0666	CbGbCtD
Tasosartan—CYP3A4—Rufinamide—epilepsy syndrome	0.0386	0.0566	CbGbCtD
Tasosartan—CYP3A4—Carbamazepine—epilepsy syndrome	0.0376	0.0552	CbGbCtD
Tasosartan—CYP3A4—Primidone—epilepsy syndrome	0.0351	0.0515	CbGbCtD
Tasosartan—CYP3A4—Phenytoin—epilepsy syndrome	0.0337	0.0495	CbGbCtD
Tasosartan—CYP3A4—Propofol—epilepsy syndrome	0.0314	0.0462	CbGbCtD
Tasosartan—CYP3A4—Acetazolamide—epilepsy syndrome	0.03	0.0441	CbGbCtD
Tasosartan—CYP3A4—Phenobarbital—epilepsy syndrome	0.03	0.0441	CbGbCtD
Tasosartan—CYP3A4—Midazolam—epilepsy syndrome	0.0296	0.0435	CbGbCtD
Tasosartan—CYP3A4—Diazepam—epilepsy syndrome	0.0285	0.0418	CbGbCtD
Tasosartan—CYP3A4—Zonisamide—epilepsy syndrome	0.0278	0.0408	CbGbCtD
Tasosartan—CYP3A4—Valproic Acid—epilepsy syndrome	0.0225	0.033	CbGbCtD
Tasosartan—CYP3A4—Topiramate—epilepsy syndrome	0.0203	0.0297	CbGbCtD
Tasosartan—Irbesartan—JUN—epilepsy syndrome	0.00261	0.421	CrCbGaD
Tasosartan—Olmesartan—ABCC2—epilepsy syndrome	0.00128	0.206	CrCbGaD
Tasosartan—Irbesartan—CYP2D6—epilepsy syndrome	0.000511	0.0826	CrCbGaD
Tasosartan—Valsartan—ALB—epilepsy syndrome	0.000505	0.0816	CrCbGaD
Tasosartan—Losartan—CYP2C19—epilepsy syndrome	0.000444	0.0718	CrCbGaD
Tasosartan—Candesartan—ABCB1—epilepsy syndrome	0.000365	0.059	CrCbGaD
Tasosartan—Losartan—ALB—epilepsy syndrome	0.000247	0.0398	CrCbGaD
Tasosartan—Losartan—ABCB1—epilepsy syndrome	0.000235	0.038	CrCbGaD
Tasosartan—AGTR1—Signaling by GPCR—CHRM3—epilepsy syndrome	8.26e-05	0.000264	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—S100B—epilepsy syndrome	8.22e-05	0.000263	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SOCS3—epilepsy syndrome	8.14e-05	0.000261	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCR10—epilepsy syndrome	8.14e-05	0.000261	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CDC42—epilepsy syndrome	8.12e-05	0.00026	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—HRH3—epilepsy syndrome	7.97e-05	0.000255	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CX3CR1—epilepsy syndrome	7.92e-05	0.000253	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—AVP—epilepsy syndrome	7.87e-05	0.000252	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—OPRM1—epilepsy syndrome	7.85e-05	0.000251	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CX3CL1—epilepsy syndrome	7.76e-05	0.000248	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—BDKRB1—epilepsy syndrome	7.76e-05	0.000248	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CHRM2—epilepsy syndrome	7.76e-05	0.000248	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—GABBR1—epilepsy syndrome	7.55e-05	0.000242	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HES1—epilepsy syndrome	7.44e-05	0.000238	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CCR3—epilepsy syndrome	7.41e-05	0.000237	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	7.38e-05	0.000236	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—HRH3—epilepsy syndrome	7.24e-05	0.000232	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—FYN—epilepsy syndrome	7.23e-05	0.000231	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—NPY—epilepsy syndrome	7.22e-05	0.000231	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	7.22e-05	0.000231	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—H2AFX—epilepsy syndrome	7.21e-05	0.000231	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MEF2C—epilepsy syndrome	7.19e-05	0.00023	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CCR5—epilepsy syndrome	7.19e-05	0.00023	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—OPRM1—epilepsy syndrome	7.13e-05	0.000228	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GRM2—epilepsy syndrome	7.12e-05	0.000228	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—HTR2A—epilepsy syndrome	7.03e-05	0.000225	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CXCL2—epilepsy syndrome	6.97e-05	0.000223	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—OXT—epilepsy syndrome	6.97e-05	0.000223	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CRH—epilepsy syndrome	6.97e-05	0.000223	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—YWHAZ—epilepsy syndrome	6.95e-05	0.000222	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NGF—epilepsy syndrome	6.87e-05	0.00022	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCR3—epilepsy syndrome	6.73e-05	0.000215	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCR5—epilepsy syndrome	6.69e-05	0.000214	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—AGT—epilepsy syndrome	6.67e-05	0.000214	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—NPY—epilepsy syndrome	6.56e-05	0.00021	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HTR2A—epilepsy syndrome	6.54e-05	0.000209	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SSTR3—epilepsy syndrome	6.44e-05	0.000206	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—OXT—epilepsy syndrome	6.33e-05	0.000203	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCL3—epilepsy syndrome	6.33e-05	0.000203	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CRH—epilepsy syndrome	6.33e-05	0.000203	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CXCL2—epilepsy syndrome	6.33e-05	0.000203	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—SST—epilepsy syndrome	6.3e-05	0.000202	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CCR2—epilepsy syndrome	6.3e-05	0.000202	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ST3GAL3—epilepsy syndrome	6.3e-05	0.000202	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TSC2—epilepsy syndrome	6.22e-05	0.000199	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—AGT—epilepsy syndrome	6.21e-05	0.000199	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCR8—epilepsy syndrome	6.17e-05	0.000197	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCR9—epilepsy syndrome	6.17e-05	0.000197	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SSTR1—epilepsy syndrome	6.17e-05	0.000197	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NPY2R—epilepsy syndrome	6.17e-05	0.000197	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ARHGEF9—epilepsy syndrome	6.17e-05	0.000197	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—ADRA2A—epilepsy syndrome	6.17e-05	0.000197	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—APOE—epilepsy syndrome	6.08e-05	0.000195	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GRM3—epilepsy syndrome	6.05e-05	0.000194	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GRM4—epilepsy syndrome	6.05e-05	0.000194	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—KDR—epilepsy syndrome	5.96e-05	0.000191	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—DUSP4—epilepsy syndrome	5.94e-05	0.00019	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SSTR2—epilepsy syndrome	5.94e-05	0.00019	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CXCL12—epilepsy syndrome	5.93e-05	0.00019	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	5.93e-05	0.00019	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CNR1—epilepsy syndrome	5.82e-05	0.000186	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PLCB1—epilepsy syndrome	5.8e-05	0.000185	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GRM8—epilepsy syndrome	5.74e-05	0.000184	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PRKCB—epilepsy syndrome	5.74e-05	0.000184	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PGF—epilepsy syndrome	5.74e-05	0.000184	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—SST—epilepsy syndrome	5.72e-05	0.000183	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCR2—epilepsy syndrome	5.72e-05	0.000183	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL6ST—epilepsy syndrome	5.71e-05	0.000183	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—HTR7—epilepsy syndrome	5.68e-05	0.000182	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—POMC—epilepsy syndrome	5.62e-05	0.00018	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—ADRA2A—epilepsy syndrome	5.6e-05	0.000179	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CCL2—epilepsy syndrome	5.5e-05	0.000176	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GNAO1—epilepsy syndrome	5.47e-05	0.000175	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—OPRD1—epilepsy syndrome	5.47e-05	0.000175	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—AKT3—epilepsy syndrome	5.41e-05	0.000173	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—BDKRB2—epilepsy syndrome	5.38e-05	0.000172	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CXCL12—epilepsy syndrome	5.38e-05	0.000172	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CNR1—epilepsy syndrome	5.28e-05	0.000169	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PLCB1—epilepsy syndrome	5.26e-05	0.000168	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CHRM1—epilepsy syndrome	5.25e-05	0.000168	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GRM1—epilepsy syndrome	5.25e-05	0.000168	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCR7—epilepsy syndrome	5.25e-05	0.000168	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PDYN—epilepsy syndrome	5.25e-05	0.000168	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—POMC—epilepsy syndrome	5.23e-05	0.000167	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—HTR7—epilepsy syndrome	5.15e-05	0.000165	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCL2—epilepsy syndrome	5.11e-05	0.000164	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—HBEGF—epilepsy syndrome	5e-05	0.00016	CbGpPWpGaD
Tasosartan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	5e-05	0.00016	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CDC42—epilepsy syndrome	4.93e-05	0.000158	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GAL—epilepsy syndrome	4.93e-05	0.000158	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GFAP—epilepsy syndrome	4.93e-05	0.000158	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AKT3—epilepsy syndrome	4.91e-05	0.000157	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	4.9e-05	0.000157	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CHRM3—epilepsy syndrome	4.88e-05	0.000156	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CASP2—epilepsy syndrome	4.88e-05	0.000156	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GRM5—epilepsy syndrome	4.88e-05	0.000156	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	4.87e-05	0.000156	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	4.83e-05	0.000155	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	4.8e-05	0.000154	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—AVP—epilepsy syndrome	4.78e-05	0.000153	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CX3CR1—epilepsy syndrome	4.68e-05	0.00015	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—FGF2—epilepsy syndrome	4.62e-05	0.000148	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CHRM2—epilepsy syndrome	4.59e-05	0.000147	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—BDKRB1—epilepsy syndrome	4.59e-05	0.000147	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CX3CL1—epilepsy syndrome	4.59e-05	0.000147	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CDC42—epilepsy syndrome	4.48e-05	0.000143	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GABBR1—epilepsy syndrome	4.46e-05	0.000143	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	4.4e-05	0.000141	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AVP—epilepsy syndrome	4.34e-05	0.000139	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	4.34e-05	0.000139	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—RELA—epilepsy syndrome	4.29e-05	0.000137	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HRH3—epilepsy syndrome	4.28e-05	0.000137	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—OPRM1—epilepsy syndrome	4.21e-05	0.000135	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MTOR—epilepsy syndrome	4.21e-05	0.000135	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CCR5—epilepsy syndrome	4.06e-05	0.00013	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	4.05e-05	0.00013	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCR3—epilepsy syndrome	3.98e-05	0.000127	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—HTR2A—epilepsy syndrome	3.98e-05	0.000127	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—AKT1—epilepsy syndrome	3.91e-05	0.000125	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NPY—epilepsy syndrome	3.88e-05	0.000124	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ATP2A2—epilepsy syndrome	3.88e-05	0.000124	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CASP3—epilepsy syndrome	3.87e-05	0.000124	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—AGT—epilepsy syndrome	3.77e-05	0.000121	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—JUN—epilepsy syndrome	3.76e-05	0.00012	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HSPB1—epilepsy syndrome	3.74e-05	0.00012	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CXCL2—epilepsy syndrome	3.74e-05	0.00012	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—OXT—epilepsy syndrome	3.74e-05	0.00012	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CRH—epilepsy syndrome	3.74e-05	0.00012	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCL3—epilepsy syndrome	3.74e-05	0.00012	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCR5—epilepsy syndrome	3.69e-05	0.000118	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MMP9—epilepsy syndrome	3.66e-05	0.000117	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—HTR2A—epilepsy syndrome	3.61e-05	0.000115	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—AKT1—epilepsy syndrome	3.55e-05	0.000113	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PRKCB—epilepsy syndrome	3.49e-05	0.000111	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TSC1—epilepsy syndrome	3.48e-05	0.000111	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PTK2B—epilepsy syndrome	3.48e-05	0.000111	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AGT—epilepsy syndrome	3.43e-05	0.00011	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SST—epilepsy syndrome	3.38e-05	0.000108	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCR2—epilepsy syndrome	3.38e-05	0.000108	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NTRK2—epilepsy syndrome	3.38e-05	0.000108	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SRC—epilepsy syndrome	3.37e-05	0.000108	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CA13—epilepsy syndrome	3.35e-05	0.000107	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—DUSP6—epilepsy syndrome	3.35e-05	0.000107	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ADRA2A—epilepsy syndrome	3.31e-05	0.000106	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PLAT—epilepsy syndrome	3.3e-05	0.000105	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—VEGFA—epilepsy syndrome	3.28e-05	0.000105	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CXCL12—epilepsy syndrome	3.18e-05	0.000102	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—BDKRB2—epilepsy syndrome	3.18e-05	0.000102	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—POMC—epilepsy syndrome	3.17e-05	0.000102	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PRKCB—epilepsy syndrome	3.16e-05	0.000101	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL6ST—epilepsy syndrome	3.15e-05	0.000101	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CNR1—epilepsy syndrome	3.12e-05	9.98e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—JUNB—epilepsy syndrome	3.12e-05	9.98e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PLCB1—epilepsy syndrome	3.11e-05	9.95e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HTR7—epilepsy syndrome	3.04e-05	9.74e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HBEGF—epilepsy syndrome	2.96e-05	9.46e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AKT3—epilepsy syndrome	2.9e-05	9.28e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—POMC—epilepsy syndrome	2.88e-05	9.22e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ADAM10—epilepsy syndrome	2.83e-05	9.07e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCL2—epilepsy syndrome	2.82e-05	9.02e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—S100B—epilepsy syndrome	2.68e-05	8.57e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SOCS3—epilepsy syndrome	2.65e-05	8.49e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CDC42—epilepsy syndrome	2.65e-05	8.47e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AVP—epilepsy syndrome	2.56e-05	8.2e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—FAR1—epilepsy syndrome	2.54e-05	8.13e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ADK—epilepsy syndrome	2.54e-05	8.13e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	2.54e-05	8.13e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	2.54e-05	8.13e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CERS1—epilepsy syndrome	2.54e-05	8.13e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PDXK—epilepsy syndrome	2.54e-05	8.13e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HES1—epilepsy syndrome	2.42e-05	7.75e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FYN—epilepsy syndrome	2.36e-05	7.54e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—H2AFX—epilepsy syndrome	2.35e-05	7.51e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MEF2C—epilepsy syndrome	2.34e-05	7.5e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	2.32e-05	7.43e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PNPO—epilepsy syndrome	2.32e-05	7.43e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	2.32e-05	7.43e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GAMT—epilepsy syndrome	2.32e-05	7.43e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—YWHAZ—epilepsy syndrome	2.27e-05	7.25e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NGF—epilepsy syndrome	2.24e-05	7.17e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCR5—epilepsy syndrome	2.18e-05	6.97e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CA4—epilepsy syndrome	2.16e-05	6.91e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—QDPR—epilepsy syndrome	2.16e-05	6.91e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	2.15e-05	6.89e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HTR2A—epilepsy syndrome	2.13e-05	6.82e-05	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—AKT1—epilepsy syndrome	2.1e-05	6.7e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—COX3—epilepsy syndrome	2.03e-05	6.5e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TSC2—epilepsy syndrome	2.03e-05	6.48e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AGT—epilepsy syndrome	2.02e-05	6.47e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—APOE—epilepsy syndrome	1.98e-05	6.34e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KDR—epilepsy syndrome	1.94e-05	6.21e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.93e-05	6.16e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.93e-05	6.16e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.93e-05	6.16e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.93e-05	6.16e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.93e-05	6.16e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PRKCB—epilepsy syndrome	1.87e-05	5.98e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL6ST—epilepsy syndrome	1.86e-05	5.96e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.76e-05	5.63e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.76e-05	5.63e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.76e-05	5.63e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—POMC—epilepsy syndrome	1.7e-05	5.45e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.7e-05	5.42e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCL2—epilepsy syndrome	1.67e-05	5.33e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.64e-05	5.24e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.64e-05	5.24e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.54e-05	4.92e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FGF2—epilepsy syndrome	1.51e-05	4.82e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.5e-05	4.79e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.46e-05	4.67e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.46e-05	4.67e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RELA—epilepsy syndrome	1.4e-05	4.47e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.39e-05	4.45e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.39e-05	4.45e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MTOR—epilepsy syndrome	1.37e-05	4.39e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.36e-05	4.36e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.33e-05	4.27e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.31e-05	4.19e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.28e-05	4.11e-05	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.27e-05	4.07e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CASP3—epilepsy syndrome	1.26e-05	4.03e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—JUN—epilepsy syndrome	1.22e-05	3.92e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.2e-05	3.84e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MMP9—epilepsy syndrome	1.19e-05	3.81e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.17e-05	3.73e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AKT1—epilepsy syndrome	1.16e-05	3.7e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SRC—epilepsy syndrome	1.1e-05	3.51e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—VEGFA—epilepsy syndrome	1.07e-05	3.42e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.06e-05	3.38e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.06e-05	3.38e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	8.6e-06	2.75e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	8.38e-06	2.68e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	8.33e-06	2.66e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	7.52e-06	2.4e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	7.16e-06	2.29e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—BCHE—epilepsy syndrome	7.13e-06	2.28e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AKT1—epilepsy syndrome	6.83e-06	2.18e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	6.8e-06	2.17e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	6.72e-06	2.15e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—TH—epilepsy syndrome	6.7e-06	2.14e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	5.59e-06	1.79e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CAT—epilepsy syndrome	5.52e-06	1.77e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	5.37e-06	1.72e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GPX1—epilepsy syndrome	4.99e-06	1.6e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—AGT—epilepsy syndrome	4.38e-06	1.4e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—APOE—epilepsy syndrome	4.29e-06	1.37e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—POMC—epilepsy syndrome	3.68e-06	1.18e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALB—epilepsy syndrome	3.36e-06	1.07e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.94e-06	9.4e-06	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.48e-06	4.72e-06	CbGpPWpGaD
